MED Medartis Holding AG

136.22USD114.80 CHF · SWX0.00%Mkt Cap: 1.70B USDP/E: 95.67

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fr…

Institutional holders10 on file

Key Statistics

Company
Market Cap1.70B USD
Enterprise Value1.91B USD
Revenue (TTM)364.36M USD
Gross Profit242.46M USD
Net Income (TTM)9.91M USD
Revenue/Share29.31 USD
Last Price136.22 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.4K
CountryCH
SectorHealthcare
IndustryMedical Devices
ISINCH0386200239
Valuation
P/E (Trailing)95.67
P/E (Forward)48.30
PEG—
EV/EBITDA55.38
EV/Revenue5.24
P/S4.65
P/B5.07
EPS (TTM)1.42 USD
EPS (Forward)2.82 USD
52W Range
83.7899% of range136.70
52W High136.70 USD
52W Low83.78 USD
Profitability
Gross Margin75.89%
Oper. Margin2.90%
EBITDA Margin9.47%
Profit Margin3.10%
ROE3.03%
ROA1.49%
ROIC0.35%
ROCE0.41%
Growth
Revenue Growth30.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF41.31M USD
CapEx (TTM)30.23M USD
FCF Margin-9.87%
FCF Yield-2.12%
Net Debt215.32M USD
Net Debt/EBITDA6.24
Net Debt/FCF—
Balance Sheet
Debt/Equity0.57
Current Ratio3.36
Quick Ratio1.62
Book Value/Sh26.87 USD
Cash/Share2.46 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)146.85 USD
Upside (mean)+7.8%
Target Range113.92 USD – 177.99 USD
113.92+7.8% to mean177.99
# Analysts4
Ownership
Shares Out.12.45M
Float4.69M
Insiders58.44%
Institutions27.85%
Technical
SMA 50109.61 (+24.3%)
SMA 200101.40 (+34.3%)
Beta1.09
S&P 52W Chg12.00%
Avg Vol (30d)16.16K
Avg Vol (10d)20.05K
Technical Indicators
RSI (14)78.0
MACD6.2053
MACD Signal5.8416
MACD Hist.+0.3637
BB Upper142.15 USD
BB Middle125.03 USD
BB Lower107.92 USD
BB Width27.37%
ATR (14)3.864 USD
Vol Ratio (20d)0.93x

About Medartis Holding (SWX: MED)

›

Medartis Holding (SWX: MED) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 1,428 employees.

The shares were at 114.80 CHF on 19 November 2026, up 52.9% over 52 weeks. Its 52-week range is 70.60 CHF to 115.20 CHF, and it trades at the top of that range.

At a market capitalisation of 1.43B CHF, it trades at 95.7 times trailing earnings and 48.3 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 273% for MED.

Medartis Holding reports return on equity of 3.0%, an operating margin of 2.9% and revenue up 30.7% year over year.

Its debt exceeds its cash by 181.45M CHF, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 123.75 CHF is 7.8% above the current price. The next earnings report is expected on 16 March 2027.